cemka > Publications > 2015

Classer les publications sur l'année

  • Économie de la santĂ©

    Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals

    LE MONNIER A, DUBURCQ A, ZAHAR JR, CORVEC S, GUILLARD T, CATTOIR V, WOERTHER PL, FIHMAN V, LALANDE V, JACQUIER H, MIZRAHI A, FARFOUR E, MORAND P, MARCADÉ G, COULOMB S, TORRETON E, FAGNANI F, BARBUT F, GMC STUDY GROUP

    J Hosp Infect ; 2015;91:117-122

  • Économie de la santĂ©

    Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study.

    DARBÀ J, KASKENS L, DETOURNAY B, KERN W, NICOLUCCI A, OROZCO-BELTRAN D, RAMIREZ DE ARELLANO A

    ClinicoEconomics and Outcomes Research ; 2015;7:163-171

  • Pharmaco-EpidĂ©miologie

    Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.

    PHILIPPE F, BLIN P, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.

    Value Health ; 2015;18(7):A382

  • Économie de la santĂ©

    Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.

    BLIN P, PHILIPPE F, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.

    Value Health ; 2015;18(7):A386

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Anemia Management Practice in French Hemodialysis Centers.

    ROTTEMBOURG J, URENA TORRES P, LE MONIES DE SAGAZAN H, SIRAJEDINE K, EMERY C, ZAKIN L, WERNLI J, MAHI L.

    Br J Med Med Res ; 2015;5(11):1338-1348

  • Économie de la santĂ©

    Utilisation de l’insuline en France : les chiffres clĂ©s

    DETOURNAY B

    Diabétologie Pratique - congrÚs 1er avril 2015 ;

  • Économie de la santĂ©

    Prise en charge et coûts de la bronchopneumopathie chronique obstructive en France en 2011

    LAURENDEAU C, CHOUAID C, ROCHE N, TERRIOUX P, GOURMELEN J , DETOURNAY B

    Rev Mal Respir ; 2015;32:682-91

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database

    RAFFI F, YAZDANPANAH Y, FAGNANI F, LAURENDEAU C, LAFUMA A, GOURMELEN J

    J Antimicrob Chemother ; 2015;70:2121-2128

  • Économie de la santĂ©

    Le coĂ»t de l’insulinothĂ©rapie en France chez les patients diabĂ©tiques de type 2

    DETOURNAY B, BUREAU I, GOURMELEN J

    MĂ©decine des maladies MĂ©taboliques ; 2015;9:3S30-3S33

  • Pharmaco-EpidĂ©miologie

    Impact of socioeconomic status on health and quality of care in adults with type 2 diabetes in France: the Entred 2007 study

    FOSSE-EDORH S, FAGOT-CAMPAGNA A, DETOURNAY B, BIHAN H, ESCHWEGE E, GAUTIER A, DRUET C

    Diabet Med ; 2015;32(11):1438-1444

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database

    DETOURNAY B, HALIMI S, ROBERT J, DESCHASEAUX C, DEJAGER S

    Vasc Health Risk Manag ; 2015;11:417-25

  • Économie de la santĂ©

    Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals

    LE MONNIER A, DUBURCQ A, ZAHAR JR, CORVEC S, GUILLARD T, CATTOIR V, WOERTHER PL, FIHMAN V, LALANDE V, JACQUIER H, MIZRAHI A, FARFOUR E, MORAND P, MARCADÉ G, COULOMB S, TORRETON E, FAGNANI F, BARBUT F, GMC STUDY GROUP

    J Hosp Infect ; 2015;91:117-22

  • Pharmaco-EpidĂ©miologie

    Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

    RICHETTE P, CLERSON P, BOUÉE S, CHALÈS G, DOHERTY M, FLIPO RM, LAMBERT C, LIOTE F, POIRAUD T, SCHAEVERBEKE T, BARDIN T.

    Ann Rheum Dis ; 2015;74(9);1684-1690